Conference Day 1
25 June 2026 (Thursday)
| TIME | TRACK 1 | TRACK 2 |
| 0745 - 0815 | Registration | |
| 0815 - 0830 | Welcome Address | |
| 0830 - 0900 | Special Lecture | |
| 0900 - 0915 | MMA Membership Drive | |
| 0915 - 0930 | Tea Break | |
| 0930 - 1045 | Symposium 1: ACS Management of STEMI Chairpersons: Tan Chen Ting, Ang Choon Kiat
|
Symposium 2: Heart Failure Acute Decompensated Heart Failure Chairpersons: Cham Yee Ling, Chan Wei Ling
|
| 1045 - 1130 | Symposium 3: Valvular Heart Disease Aortic Stenosis Chairpersons: Oon Yen Yee, Chan Boon Cheng
|
Symposium 4: Atrial Fibrillation and Arrhythmias Diagnosis of Palpitations and Anticoagulation for AF Chairpersons: Koh Keng Tat, Foo Jhi Hui
|
| 1130 - 1145 | Tea Break | |
| 1145 - 1230 | Symposium 5: Chronic Coronary Syndrome Diagnosing Coronary Artery Disease Chairpersons: Ling Hwei Sung, Tan Sian KongDiagnosing Coronary Artery Disease – My PracticeVoon Chi YenPhysiology-Guided PCI for CCS.Tan Chen TingCABG for CCS – For Whom and WhenJong Yuan Hsun |
Symposium 6: Hypertension Treatment Options of The Modern Era Chairpersons: Francis Shu, Rowland ChinPearls of Hypertension TreatmentChin Sze PiawRenal Denervation For Uncontrolled HypertensionOng Tiong KiamCombination Therapy To Improve Control of HypertensionLiew Chee Khoon |
| 1230 - 1315 | Symposium 7: Dyslipidaemia New Treatment Strategies for LDL-C Chairpersons: Asri Said, Yew Kuan LeongModern Treatments For LDL ReductionAng Choon KiatCombination Therapy To Improve LDL ControlChan Wei LingLower LDL Levels Stabilizes The Vulnerable PlaqueChandan Deepak Bhanvani |
Symposium 8: Research and Clinical Trials Research Ecosystem In Clinical Service Chairpersons: Alan Fong, Chin Sze PiawResearch at Sarawak Heart Centre – Local To Global ImpactAlan FongPulmonary Artery Denervation – Overview Clinical Trial ProgramChen Shao-LiangAn Update of Ongoing Clinical TrialsTBC |
| 1315 - 1415 | Lunch Symposium A | Lunch Symposium B |
| 1415 - 1500 | Symposium 9: Diabetes and Heart Failure Managing Patients with DM and HF Chairpersons: Joshua Chung, Liew Chee KhoonCombination Strategies For Patients With DM and HFChua Seng KeongKey Updates From Heart Failure GuidelinesTan Sian KongClinical Case ReviewsSiti Alis Solihan Ramli |
Symposium 10: Pulmonary Embolism, Peripheral Vascular Disease and Aortic Dissection Vascular Disease Beyond The Heart Chairpersons: Pang Ing Xiang, Chua Seng Keong
|
| 1500 - 1545 | Symposium 11: Congenital Heart Disease Congenital Heart Disease From A Child To Adulthood Chairpersons: Martin Wong, Prashant JoshiASDIsaac ChanVSDPrashant JoshiTaking Care of GUCH Patients – A 20-year JourneyMartin Wong |
Symposium 12: Heart Disease in Pregnancy Contemporary Management of Pregnant Patients With Heart Disease Chairpersons: Ling Hwei Sung, Meity ArdianaPeripartum Cardiomyopathy – An OverviewJulian TongHypertension In PregnancyCheah Cheng FoongScreening For Heart Disease In Pregnant Patients – Who And When?Liew Houng Bang |
| 1545 - 1600 | Tea Break | |
| 1600 - 1645 | Symposium 13: Cardiomyopathies New Diagnoses and Precision Therapeutics for Cardiomyopathies Chairpersons: Oon Yen Yee, Chen Lean Seng
|
Symposium 14: Training Opportunities With The Department of Cardiology Advanced Training for Doctors, Nurses and Medical Assistants Chairpersons: Ong Tiong Kiam, Liew Houng Bang
|
Conference Day 2
26 June 2026 (Friday)
| TIME | TRACK 1 | TRACK 2 |
| 0900 – 0945 | Symposium 15: ACS NSTEMI and Unstable Angina Chairpersons: Francis Shu, Khiew Ning Zan
|
Symposium 16: Heart Failure Chronic Heart Failure - Syndromes and Management Chairpersons: Cham Yee Ling, Khaw Chee Sin
|
| 0945 – 1030 | Symposium 17: Valvular Heart Disease Mitral Valve Disease Chairpersons: Asri Said, Prashant Joshi
|
Symposium 18: Atrial Fibrillation Rate vs Rhythm Control Chairpersons: Koh Keng Tat, Thien Lee Karl
|
| 1030 – 1145 | Lunch Symposium C | Lunch Symposium D |
| 1145 – 1230 | Symposium 19: Chronic Coronary Syndrome Ischaemic Cardiomyopathy - Diagnosis to Treatments Chairpersons: Pang Ing Xiang, Voon Chi Yen
|
Symposium 20: Dyslipidaemia Diagnostics and Therapeutics For Dyslipidaemia Chairpersons: Alan Fong, Ho Kian HuiWhich Patients With Dyslipidaemia Has The Highest CV Risk?Ho Weng KeeModern LDL Treatments In My Clinical PracticeYew Kuan LeongNovel LDL Therapies On The HorizonAlan Fong |
| 1230– 1245 | Closing | |
DISCLAIMER: Whilst every attempt would be made to ensure all aspects of the conference mentioned in the Programme will take place as scheduled, the Organising Committee takes no responsibility should it fail to materialise due to any unforeseen circumstances.
